Cynthia M Butitta - Net Worth and Insider Trading
Cynthia M Butitta Net Worth
The estimated net worth of Cynthia M Butitta is at least $22 Million dollars as of 2024-05-27. Cynthia M Butitta is the COO of Kite Pharma Inc and owns about 121,567 shares of Kite Pharma Inc (KITE) stock worth over $22 Million. Cynthia M Butitta is also the COO and CFO of MabVax Therapeutics Holdings Inc and owns about 7 shares of MabVax Therapeutics Holdings Inc (MBVXQ) stock worth over $0. Details can be seen in Cynthia M Butitta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cynthia M Butitta has not made any transactions after 2017-09-25 and currently still holds the listed stock(s).
Transaction Summary of Cynthia M Butitta
Cynthia M Butitta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cynthia M Butitta owns 5 companies in total, including UroGen Pharma Ltd (URGN) , Kite Pharma Inc (KITE) , and MabVax Therapeutics Holdings Inc (MBVXQ) among others .
Click here to see the complete history of Cynthia M Butitta’s form 4 insider trades.
Insider Ownership Summary of Cynthia M Butitta
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2019-01-01 | director |
| KITE | Kite Pharma Inc | 2017-10-03 | Chief Operating Officer |
| MBVXQ | MabVax Therapeutics Holdings Inc | 2009-11-18 | COO and CFO |
 | | 2020-11-18 | director |
| | 2022-06-09 | director |
Cynthia M Butitta Latest Holdings Summary
Cynthia M Butitta currently owns a total of 2 stocks. Among these stocks, Cynthia M Butitta owns 121,567 shares of Kite Pharma Inc (KITE) as of September 25, 2017, with a value of $22 Million and a weighting of 100%. Cynthia M Butitta also owns 7 shares of MabVax Therapeutics Holdings Inc (MBVXQ) as of August 10, 2006, with a value of $0 and a weighting of 0%.
Latest Holdings of Cynthia M Butitta
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KITE | Kite Pharma Inc | 2017-09-25 | 121,567 | 179.79 | 21,856,531 |
| MBVXQ | MabVax Therapeutics Holdings Inc | 2006-08-10 | 7 | 0.02 | 0 |
Holding Weightings of Cynthia M Butitta
Cynthia M Butitta Form 4 Trading Tracker
According to the SEC Form 4 filings, Cynthia M Butitta has made a total of 0 transactions in Kite Pharma Inc (KITE) over the past 5 years. The most-recent trade in Kite Pharma Inc is the sale of 4,228 shares on September 25, 2017, which brought Cynthia M Butitta around $759,602.
According to the SEC Form 4 filings, Cynthia M Butitta has made a total of 0 transactions in MabVax Therapeutics Holdings Inc (MBVXQ) over the past 5 years. The most-recent trade in MabVax Therapeutics Holdings Inc is the acquisition of 1 shares on August 10, 2006, which cost Cynthia M Butitta around $77,350.
Insider Trading History of Cynthia M Butitta
- 1
Cynthia M Butitta Trading Performance
GuruFocus tracks the stock performance after each of Cynthia M Butitta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cynthia M Butitta is 19.49%. GuruFocus also compares Cynthia M Butitta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cynthia M Butitta within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cynthia M Butitta's insider trading performs compared to the benchmark.
Performance of Cynthia M Butitta
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.52 | | | | | |
| Relative Return to S&P 500(%) | 7.39 | | | | | |
Cynthia M Butitta Ownership Network
Cynthia M Butitta Owned Company Details
What does UroGen Pharma Ltd do?
Who are the key executives at UroGen Pharma Ltd?
Cynthia M Butitta is the director of UroGen Pharma Ltd. Other key executives at UroGen Pharma Ltd include Chief Medical Officer Mark Schoenberg , General Counsel Jason Drew Smith , and Chief Financial Officer Dong Kim .
UroGen Pharma Ltd (URGN) Insider Trades Summary
Over the past 18 months, Cynthia M Butitta made no insider transaction in UroGen Pharma Ltd (URGN). Other recent insider transactions involving UroGen Pharma Ltd (URGN) include a net sale of 21,478 shares made by Mark Schoenberg , and a net sale of 15,422 shares made by Jason Drew Smith .
In summary, during the past 3 months, insiders sold 12,000 shares of UroGen Pharma Ltd (URGN) in total and bought 0 shares, with a net sale of 12,000 shares. During the past 18 months, 36,900 shares of UroGen Pharma Ltd (URGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 36,900 shares.
UroGen Pharma Ltd (URGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
UroGen Pharma Ltd Insider Transactions
Cynthia M Butitta Mailing Address
Above is the net worth, insider trading, and ownership report for Cynthia M Butitta. You might contact Cynthia M Butitta via mailing address: 3165 Porter Drive, Palo Alto Ca 94304.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
